Background As many as 89% of people with Parkinson's disease (PD) develop speech
disorders. Objectives This randomized controlled trial evaluated two speech treatments for …

Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and
voice disorders including disorders of laryngeal, respiratory and articulatory function …

Parkinson's disease (PD) results from neurodegenerative processes leading to alteration of
motor functions. Most motor symptoms respond well to pharmacological and neurosurgical …

Evidence-based treatment of voice and speech disorders in Pa... : Current Opinion in
Otolaryngology & Head and Neck Surgery Evidence-based treatment of voice and speech …

This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal
loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic …

Speech therapy in PD patients, focusing on an increase of phonatory–respiratory effort, has
adverse effects because it raises vocal pitch and laryngeal muscle tension. The authors' …

Objective The purpose of the present retrospective study was to examine the effects of
intensive voice therapy on facial expression in Parkinson disease. Background Parkinson …

Background Parkinson's disease patients commonly suffer from speech and vocal problems
including dysarthric speech, reduced loudness and loss of articulation. These symptoms …

Researchers estimate that 89% of people with Parkinson's disease (PD) have a speech or
voice disorder including disorders of laryngeal, respiratory, and articulatory function. Despite …

Speech and swallowing disorders in Parkinson disease : Current Opinion in Otolaryngology &
Head and Neck Surgery Speech and swallowing disorders in Parkinson disease : Current …